Endocrine Testing Market Progressing At A CAGR Of 8.0% For The Forecast Period From 2018 To 2024 : Grand View Research Inc.
San Francisco, 20 September 2019: The Report Endocrine Testing Market Size, Share & Trends Analysis Report By Test Type, By Technology (Tandem Mass Spectrometry, Immunoassay), By End-use And Segment Forecasts, 2018 – 2024 The global endocrine testing market is expected to reach USD 13.02 billion by 2024, according to a new report by Grand View Research, Inc. Increasing geriatric population and growing rate of diseases such as obesity and diabetes is expected to drive the market growth. The presence of a large population over 60 years, having lower immunity levels and are prone to neurological diseases, cardiac problems, cancers, and spinal injuries, is a high impact-rendering driver for the growth of endocrine testing market over the forecast period. Sedentary lifestyles of people with unhealthy food habits and increasing stress levels resulted in an increase in the diabetic and obese population. This demographic is highly susceptible to endocrine diseases and is antici